Intec Pharma Ltd. Partnered With LTS Lohmann Therapie-Systeme AG ("LTS") For Levodopa Market

 

Levodopa Market

Advancement in the diagnosis of Parkinson's disease (PD) progression is propelling the growth of the levodopa market. For instance, researchers continue developing new treatments for Parkinson's disease, treatments that give real hope for people suffering from the disease. Some treatments currently being studied involve fetal cell transplantation, the use of stem cells, and gene therapy. Moreover, the development of novel formulations and drug delivery methods for levodopa is also contributing to the growth of the levodopa market.

Levodopa is known by many names, including chelation therapy, L-carnitine, and nutritive adjuvant. It is a naturally occurring substance found in most tissues of the body, including the brain, heart, liver, kidney, pancreas, lungs, stomach, small intestine, and skeletal muscle tissue. This substance is often taken to treat various diseases, including Parkinson's disease and depression. As dopamine is responsible for feelings such as pleasure and excitement and is one of the neurotransmitters affected by disorders such as Parkinson's, using levodopa can help reduce some of these symptoms. Additionally, this substance has been shown to have beneficial effects on mood disorders, especially bipolar disorder. Levodopa can be taken in pill form

1.     In August 2019, The U.S. Food and Drug The administration approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) experiencing "off" episodes

2.     In February 2021, Adamas Pharmaceuticals, Inc. a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases announced it has received marketing authorization from the U.S. Food and Drug Administration (FDA) for a supplemental New Drug Application for GOCOVRI® (amantadine) extended-release capsules, gaining a second indication for the product.

3.     In March 2018, Intec Pharma Ltd. announces that it has partnered with LTS Lohmann Therapie-Systeme AG ("LTS") for the manufacture of the Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD) as a treatment for the severe symptoms in advanced Parkinson's disease patients.

North America is expected to dominate the global levodopa market and this is attributed to the high prevalence rate of Parkinson's disease in the region. According to the Parkinson's Foundation, nearly one million will be living with Parkinson's disease (PD) in the U.S. by 2020. Approximately 60,000 Americans are diagnosed with PD each year. More than 10 million people worldwide are living with PD. Men are 1.5 times more likely to have Parkinson's disease than women.

Comments

Post a Comment

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Image
  With billions of dollars in research and development costs, pharmaceutical companies around the world are always looking for new ways to address their production processes in a cost-effective manner. One way to achieve this is through outsourcing drug discovery and development services. This type of service refers to the collaboration between small and large biotech and biotechnology companies to conduct research and development activities aimed at finding better solutions to the company's core chemical concerns. Outsourcing of these drug discovery services has enabled established pharmaceutical and biotechnology companies to focus on the development of new products that can bring about significant therapeutic change and provide tangible advantages to the company's shareholders. Contract research organizations manage almost all aspects of drug discovery. Market Dynamics I ncreasing demand for outsourcing analytical testing and clinical trial services, growing R&D ex...
Read more

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis

Image
  An otoscope or auricular ear picker is a simple health care tool that is used to inspect the outer ear. Many health care professionals utilize otoscopes to examine ear infections during routine check-ups and to also screen for serious ear disorders. An otoscope possibly provides a more detailed view of the external ear canal and/or ear drum or eardrum. Otoscope or also referred to as auriscope is mainly used to look into eyes. The demand for these medical devices has been on a rise in the recent past. This is typically due to the fact that there is a high burden of ENT-related diseases across the globe. As per the World Health Organization (WHO), by 2050, around 2.5 billion people are estimated to have some degree of hearing loss worldwide. Similarly, there is a heavy burden of sinusitis cases. As per the Sinusitis & Allergy Wellness Center, around 30 million adults in the U.S. are impacted with sinusitis annually. Such a high prevalence of ENT disorders has accelerated the d...
Read more

The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market

Image
  North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood c...
Read more